Hsbc Holdings PLC Has $53.27 Million Stake in Tenet Healthcare Corporation $THC

Hsbc Holdings PLC boosted its position in shares of Tenet Healthcare Corporation (NYSE:THC) by 3,478.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 266,400 shares of the company’s stock after purchasing an additional 258,956 shares during the period. Hsbc Holdings PLC’s holdings in Tenet Healthcare were worth $53,269,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of THC. Triumph Capital Management bought a new position in shares of Tenet Healthcare during the third quarter worth about $25,000. Activest Wealth Management acquired a new position in Tenet Healthcare during the 4th quarter worth approximately $26,000. Elyxium Wealth LLC acquired a new stake in shares of Tenet Healthcare in the fourth quarter valued at approximately $29,000. Meeder Asset Management Inc. lifted its position in shares of Tenet Healthcare by 146.2% in the fourth quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock worth $38,000 after purchasing an additional 114 shares in the last quarter. Finally, Canada Pension Plan Investment Board acquired a new stake in Tenet Healthcare in the 2nd quarter valued at $35,000. 95.44% of the stock is owned by institutional investors and hedge funds.

Tenet Healthcare Price Performance

Shares of NYSE THC opened at $180.74 on Wednesday. The company has a quick ratio of 1.30, a current ratio of 1.36 and a debt-to-equity ratio of 1.96. The business’s 50 day moving average price is $181.69 and its two-hundred day moving average price is $197.96. The company has a market cap of $15.57 billion, a PE ratio of 9.40, a price-to-earnings-growth ratio of 1.47 and a beta of 1.28. Tenet Healthcare Corporation has a twelve month low of $146.60 and a twelve month high of $247.21.

Tenet Healthcare (NYSE:THC) last issued its earnings results on Thursday, April 30th. The company reported $4.82 EPS for the quarter, topping the consensus estimate of $4.21 by $0.61. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The company had revenue of $5.37 billion during the quarter, compared to the consensus estimate of $5.39 billion. During the same period in the previous year, the company posted $4.36 EPS. The firm’s revenue for the quarter was up 2.6% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. On average, analysts predict that Tenet Healthcare Corporation will post 17.61 EPS for the current year.

Wall Street Analyst Weigh In

A number of research firms have recently commented on THC. Morgan Stanley set a $254.00 price objective on shares of Tenet Healthcare in a research note on Friday, May 1st. Wall Street Zen lowered Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, May 11th. Wells Fargo & Company lowered their price target on Tenet Healthcare from $265.00 to $213.00 and set an “overweight” rating on the stock in a research report on Friday, May 1st. TD Cowen cut their price objective on Tenet Healthcare from $242.00 to $233.00 and set a “buy” rating for the company in a report on Monday. Finally, Robert W. Baird lowered their target price on shares of Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating on the stock in a report on Tuesday, May 5th. Eighteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat, Tenet Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $244.32.

Insider Buying and Selling at Tenet Healthcare

In other Tenet Healthcare news, Director J Robert Kerrey sold 5,638 shares of the company’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $174.52, for a total value of $983,943.76. Following the transaction, the director directly owned 16,804 shares in the company, valued at $2,932,634.08. The trade was a 25.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Nadja West sold 3,000 shares of the firm’s stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total transaction of $532,050.00. Following the sale, the director owned 24,805 shares of the company’s stock, valued at approximately $4,399,166.75. This represents a 10.79% decrease in their position. The SEC filing for this sale provides additional information. 0.97% of the stock is owned by insiders.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.